Floor E Jansen
Overview
Explore the profile of Floor E Jansen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
3323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanders M, Koeleman B, Brilstra E, Jansen F, Baldassari S, Chipaux M, et al.
Epilepsia
. 2024 Oct;
65(12):e209-e215.
PMID: 39460693
We studied the distribution of germline and somatic variants in epilepsy surgery patients with (suspected) malformations of cortical development (MCD) who underwent surgery between 2015 and 2020 at University Medical...
2.
Defelippe V, Brilstra E, Otte W, Cross H, OCallaghan F, De Giorgis V, et al.
Epilepsia
. 2024 Sep;
65(11):3119-3137.
PMID: 39254637
Objective: Defined as prospective single-patient crossover studies with repeated paired cycles of active and control intervention, N-of-1 trials have gained attention as an option to obtain high-quality evidence of efficacy,...
3.
Minderhoud C, Postma A, Jansen F, Zinkstok J, Verhoeven J, Berghuis B, et al.
Brain Commun
. 2024 Sep;
6(5):fcae285.
PMID: 39239151
This cohort study aims to describe the evolution of disease features and health-related quality of life per life stage in Dravet syndrome and other -related non-Dravet seizure disorders which will...
4.
Scheper M, Sorensen F, Ruffolo G, Gaeta A, Lissner L, Anink J, et al.
Acta Neuropathol
. 2024 May;
147(1):80.
PMID: 38714540
GABAergic interneurons play a critical role in maintaining neural circuit balance, excitation-inhibition regulation, and cognitive function modulation. In tuberous sclerosis complex (TSC), GABAergic neuron dysfunction contributes to disrupted network activity...
5.
Postma A, Minderhoud C, Otte W, Jansen F, Gunning W, Verhoeven J, et al.
Epilepsy Behav
. 2024 Mar;
154:109726.
PMID: 38513571
Background: A pathogenic variant in SCN1A can result in a spectrum of phenotypes, including Dravet syndrome (DS) and genetic epilepsy with febrile seizures plus (GEFS + ) syndrome. Dravet syndrome...
6.
Sanders M, Van der Wolf I, Jansen F, Aronica E, Helmstaedter C, Racz A, et al.
Neurology
. 2024 Jan;
102(4):e208007.
PMID: 38290094
Background And Objective: Patients with presumed nonlesional focal epilepsy-based on either MRI or histopathologic findings-have a lower success rate of epilepsy surgery compared with lesional patients. In this study, we...
7.
Slinger G, Noorlag L, van Diessen E, Otte W, Zijlmans M, Jansen F, et al.
Epilepsia Open
. 2023 Dec;
9(2):548-557.
PMID: 38101810
Objective: New-onset seizure-like events (SLEs) are common in children, but differentiating between epilepsy and its mimics is challenging. This study provides an overview of the clinical characteristics, diagnoses, and corresponding...
8.
Luinenburg M, Scheper M, Sorensen F, Anink J, Van Hecke W, Korshunova I, et al.
Front Cell Neurosci
. 2023 Dec;
17:1284394.
PMID: 38089143
Introduction: Constitutive activation of the mTOR pathway, as observed in Tuberous Sclerosis Complex (TSC), leads to glial dysfunction and subsequent epileptogenesis. Although astrocytes are considered important mediators for synaptic clearance...
9.
van Arnhem M, van den Munckhof B, Arzimanoglou A, Perucca E, Metsahonkala L, Rubboli G, et al.
Lancet Neurol
. 2023 Dec;
23(2):147-156.
PMID: 38081201
Background: Epileptic encephalopathy with spike-wave activation in sleep (EE-SWAS) is a rare syndrome associated with cognitive and behavioural regression. On the basis of mostly small observational and retrospective studies, corticosteroids...
10.
Huschner F, Glowacka-Walas J, Mills J, Klonowska K, Lasseter K, Asara J, et al.
Nat Commun
. 2023 Nov;
14(1):7664.
PMID: 37996417
We present a comprehensive multi-omic analysis of the EPISTOP prospective clinical trial of early intervention with vigabatrin for pre-symptomatic epilepsy treatment in Tuberous Sclerosis Complex (TSC), in which 93 infants...